Benfotiamine

Testimonials are a great read:
http://www.benfotiamine.org/testimonials.htm


WHY HASN'T BENFOTIAMINE BEEN IN WIDESPREAD USE IN THE U.S.?
Though attempts were made by the Japanese pharmaceutical manufacturer Sankyo to market benfotiamine in the U.S. years ago, there was little interest until the recent article published in the U.S. by Dr. Brownlee. Since that time, interest in benfotiamine has increased dramatically. Read More

Diabetics form a large sub-group of those who could benefit from benfotiamine. Diabetes is an insidious malady. The adverse effects of high blood glucose must be addressed. The best course of action is proper diet, exercise and medication to control blood glucose levels. In addition, ensuring proper cellular nutrition with a safe dietary supplement to combat the metabolic effects of high blood glucose at the cellular level seems a prudent course of action.

Benfotiamine is believed to enhance in humans the activity of the enzyme transketolase, which converts harmful glucose metabolites at the cellular level into harmless chemicals, preventing damage, especially to the endothelial cells which line the small arteries and capillaries of the kidneys and retinas.

(This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.)

If benfotiamine in fact produces such an effect in humans, and anecdotal evidence along with the clinical trials cited above suggest that it does, then a regimen of benfotiamine seems called for. It is noteworthy that there have been no anecdotal nor clinical reports of toxicity or adverse side affects associated with benfotiamine after decades of public use in Japan & Europe. As noted above, the original U.S. patent for benfotiamine scientifically documents that the compound is far less toxic than thiamine hydrochloride itself (vitamin B-1). Another study concluded that benfotiamine is 30 times less toxic than acetaminophen (the active ingredient in Tylenol).

FDA DISCLAIMER: Because benfotiamine is a dietary supplement the FDA only requires manufacturers and distributors to have credible evidence as to its safety. The FDA itself has not evaluated benfotiamine for safety or effectiveness. Benfotiamine therefore cannot be represented to diagnose, treat, cure or prevent any disease. For more information on this and related topics, please follow this link to FAQ's on benfotiamine.

Alert Webmaster & Moderators Already alerted!  Already alerted!